Why a case report being circulated by advocates doesn't show that the ketogenic diet combats cancer
In conclusion, this combined metabolic approach appears effective in treating advanced TNBC, given this patient’s complete response with a good quality of life.Now, there is one thing that is interesting here. The doses of chemotherapy used were considerably lower thanwhat is usually used, with doses decreased by at least half or more. Does this mean anything? Who knows? cPR rates for TNBC have been reported to range from 20-35%. It could mean the regimen made the chemotherapy more effective, or it could mean that this woman just happened to have a particularly chemosensitive tumor. Even if we take this case report at fa...
Source: Respectful Insolence - October 4, 2017 Category: Surgery Authors: oracknows Source Type: blogs

Why a case report being circulated by advocates doesn't show that the ketogenic diet combats cancer
In conclusion, this combined metabolic approach appears effective in treating advanced TNBC, given this patient’s complete response with a good quality of life.Now, there is one thing that is interesting here. The doses of chemotherapy used were considerably lower thanwhat is usually used, with doses decreased by at least half or more. Does this mean anything? Who knows? cPR rates for TNBC have been reported to range from 20-35%. It could mean the regimen made the chemotherapy more effective, or it could mean that this woman just happened to have a particularly chemosensitive tumor. Even if we take this case report at fa...
Source: Respectful Insolence - October 4, 2017 Category: Surgery Authors: oracknows Source Type: blogs

Health 2.0 Fall Conference Startup Pitch Competition: Meet the Companies
This week, healthcare technology innovators, thought leaders, and business owners convene in Santa Clara, California for Health 2.0’s 11th Annual Fall Conference. While this year’s event runs from October 2-4, Medgadget was able to participate in the Sunday pre-conference and the annual Startup Pitch Competition. Evaluating eight “Series A ready” companies, organized into professional solution (B2B) and consumer solution (B2C) tracks, were six judges. The diverse panel of judges included: Anya Schiess from Healthy Ventures Caroline Arenz from Healthbox Alexander Hoffman from Merck Ventures Gwyn ...
Source: Medgadget - October 3, 2017 Category: Medical Devices Authors: Michael Batista Tags: Exclusive Source Type: blogs

Baby Foreskin Is Being Used To Make Vaccines
Conclusion Vaccine companies have regularly used blood and body parts from killed cows, dogs, worms, mice, chickens, human babies, monkeys, guinea pigs, rabbits, hamsters, rats, etc., to make these vaccines, so using foreskin from newborn babies may not surprise some. For many, it is appalling. [28] Circumcisions fuel multi-billion dollar industries. If you see neonatal foreskin for sale, which is very easy to find on the internet, remember that these newborn children didn’t consent to being circumcised and they didn’t consent for their foreskin to be sold, used for research purposes, or to be injected into the people ...
Source: vactruth.com - September 28, 2017 Category: Allergy & Immunology Authors: Augustina Ursino Tags: Augustina Ursino Top Stories circumcision truth about vaccines Source Type: blogs

Novo Nordisk $58 Million Settlement and REMS - Off Label Prosecution Still Alive and Well
Novo Nordisk will pay roughly $58.7 million to resolve claims that the company’s sales force downplayed the importance of mandated United States Food and Drug Administration (FDA) warnings about the cancer risks of its diabetes prescription, Victoza. In a civil complaint filed on September 5, 2017, in the U.S. District Court for the District of Columbia, the government asserted claims under the FDCA, alleging that at the time of Victoza’s approval in 2010, the FDA required a Risk Evaluation and Mitigation Strategy (REMS) to mitigate the potential risk in humans of a rare form of cancer associated with the drug - Medul...
Source: Policy and Medicine - September 13, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

Amazing Technologies Changing The Future of Dermatology
Smart algorithms will soon diagnose skin cancer, dermatologists consult patients online, and 3D printers will print out synthetic skin to fight tissue shortages. There is a lot going on in dermatology, and medical professionals should prepare in time for the technological changes before they start swiping through the specialty. Let’s start by familiarizing with the most amazing technologies changing dermatology! Your body’s best guard in a hostile world: your skin Everything is written on your skin. Every wrinkle, spot, and color tells a story, and not only a medical one. This miraculous organ can show you as a litmus ...
Source: The Medical Futurist - September 7, 2017 Category: Information Technology Authors: nora Tags: Future of Medicine Telemedicine 3d printing AI artificial intelligence dermatology digital GC1 Healthcare Innovation nanotechnology Personalized medicine robotics wearables Source Type: blogs

Fight Aging! Newsletter, August 28th 2017
In conclusion, CAVD is highly prevalent. Long understood as a passive process, it is now known to be complex and one which involves pathophysiological mechanisms similar to those of atherosclerosis. Understanding these mechanisms could help to establish new therapeutic targets that might allow us to halt or at least slow down the progression of the disease. Early Steps in the Tissue Engineering of Intervertebral Discs https://www.fightaging.org/archives/2017/08/early-steps-in-the-tissue-engineering-of-intervertebral-discs/ In this paper, researchers report on progress towards the manufacture of interve...
Source: Fight Aging! - August 27, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

The 2017 Summer Scholars Working at the SENS Research Foundation
Each year, the SENS Research Foundation accepts a group of young life science academics and puts them to work on projects in aging research, both at the foundation and in allied laboratories, creating ties between research groups that can help to advance the state of the art. This year's batch has worked on a diverse set of projects that spread out beyond core SENS initiatives such as allotopic expression of mitochondrial genes. Reading through their projects is a reminder that a great deal can be accomplished these days given a small team, a little funding, and an equipped laboratory. Progress in medical research is no lo...
Source: Fight Aging! - August 26, 2017 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs

Rapid Hepatocellular Carcinoma Test Can be Administered Anywhere
Researchers at the University of Utah have developed a rapid and highly portable liver cancer screening test, that can be administered anywhere. One of the biggest challenges in treating liver cancer is that often symptoms don’t appear until the disease is in the later stages, meaning it is important that people are tested rapidly when doctors suspect they might have it. At the moment, testing for liver cancer involves sending a blood sample to a hospital lab, which could take weeks to return the results. The testing also typically requires patients to undergo ultrasound imaging, which is difficult for people living in r...
Source: Medgadget - August 25, 2017 Category: Medical Devices Authors: Conn Hastings Tags: Diagnostics GI Oncology Pathology Source Type: blogs

The ‘Tanning Tax’ Is A Public Health Success Story
Among the lesser known provisions in the now-rejected Republican House and Senate health care bills was a plan to eliminate an excise tax on tanning bed use. Tanning first became fashionable when Coco Chanel popularized the practice in the 1920s, making lounging outside in the sun a symbol of leisure, relaxation, and health. In the late 1970s, pioneering businesses began to offer ultraviolet (UV) radiation beds as a shortcut to fashionable tanned skin; by the 1990s, indoor UV tanning services were ubiquitous staples of the American beauty industry. Despite its popularity, research has shown that exposure to UV radiation is...
Source: Health Affairs Blog - August 15, 2017 Category: Health Management Authors: Elisabeth Ryan Tags: Costs and Spending Public Health tanning tax Source Type: blogs

Choroid plexus carcinoma in an infant
Some papillary architecture is maintained (Source: neuropathology blog)
Source: neuropathology blog - August 1, 2017 Category: Radiology Tags: neoplasms Source Type: blogs

MKSAP: 34-year-old man with episodic palpitations
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 34-year-old man is evaluated for episodic palpitations of 8 months’ duration. The palpitations last 5 to 10 minutes and then resolve spontaneously. They are usually associated with sweating and anxiety. Medical history is significant for thyroidectomy for medullary thyroid carcinoma diagnosed at 12 years of age. His father has also undergone thyroidectomy for medullary thyroid cancer. His only medication is levothyroxine. On physical examination, blood pressure is 164/92 mm Hg, pulse rate is 106/min, and...
Source: Kevin, M.D. - Medical Weblog - July 29, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Endocrinology Source Type: blogs

Examining How Senate Republicans Frame Their Health Care Bill
Discussion Draft of Senate Amendment to H.R. 1628 Help stabilize collapsing insurance markets that have left millions of Americans with no options. Short-Term Stabilization Fund: To help balance premium costs and promote more choice in insurance markets throughout the country, this stabilization fund would help address coverage and access disruption – providing $15 billion per year in 2018 and 2019; $10 billion per year in 2020 and 2021. Jason Chung writes: S. 106(h)(1) specifies that these amounts are intended to “fund arrangements with health insurance issuers to address coverage and access disruption…” Rand P...
Source: The Health Care Blog - June 22, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Jason Chung Senate Bill Source Type: blogs

Don ’t Underestimate Patients
By GEORGE BERGER, PHD I was diagnosed with aggressive but localized prostate cancer at a major Dutch academic hospital. My parameters were PSA 29 or 31, Gleason sum 4 + 4, and stage T2c. Fortunately, there were no detectable distant metastases. The specialist drew a simple image of my urinary tract and told me I was excluded from brachytherapy, which I had never heard of before, because of the size of my prostate. I had to choose between external beam radiotherapy (EBRT) and radical prostatectomy (RP). How on Earth could I choose rationally while knowing so little about prostate cancer? However, I had studied maths and phy...
Source: The Health Care Blog - June 17, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized ADT Dutch Health Care System Gleason Prostate Prostate Cancer Sweden Source Type: blogs

Fight Aging! Newsletter, June 12th 2017
In this study, we focused on two pathways of cardiomyocytes or heart cells: the Hippo pathway, which is involved in stopping renewal of adult cardiomyocytes, and the dystrophin glycoprotein complex (DGC) pathway, essential for cardiomyocyte normal functions." Previous work had hinted that components of the DGC pathway may somehow interact with members of the Hippo pathway. The researchers genetically engineered mice to lack genes involved in one or both pathways, and then determined the ability of the heart to repair an injury. These studies showed for the first time that dystroglycan 1, a component of the DGC pathw...
Source: Fight Aging! - June 11, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs